Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease

NCT04084483 is registered in ClinicalTrials.gov with Kowa Research Institute, Inc. as lead sponsor.

NCT NCT04084483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04084483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
Lead sponsor
Kowa Research Institute, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 4, 2019
Completion date
January 9, 2020
Enrollment
238 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease